Mesalamine and Lipase increased - a phase IV clinical study of FDA data


Lipase increased is found among people who take Mesalamine, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Mesalamine and have Lipase increased. It is created by eHealthMe based on reports of 14,816 people who have side effects when taking Mesalamine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 17, 2022

14,816 people reported to have side effects when taking Mesalamine.
Among them, 32 people (0.22%) have Lipase increased.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 10,078 Mesalamine users for its effectiveness, alternative drugs and more.

What is Lipase increased?

Lipase increased is found to be associated with 1,514 drugs and 968 conditions by eHealthMe.

Number of Mesalamine and Lipase increased reports submitted per year:

Could Mesalamine cause Lipase increased?

Time on Mesalamine when people have Lipase increased *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Lipase increased when taking Mesalamine *:

  • female: 72.41 %
  • male: 27.59 %

Age of people who have Lipase increased when taking Mesalamine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 11.11 %
  • 20-29: 22.22 %
  • 30-39: 33.33 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 33.33 %

Common drugs people take besides Mesalamine *:

  1. Xarelto: 18 people, 56.25%
  2. Prednisone: 18 people, 56.25%
  3. Quinine: 18 people, 56.25%
  4. Atenolol: 16 people, 50.00%
  5. Sulfadiazine: 16 people, 50.00%
  6. Azathioprine: 14 people, 43.75%
  7. Omeprazole: 14 people, 43.75%
  8. Penicillin G Sodium: 13 people, 40.62%
  9. Methotrexate: 13 people, 40.62%
  10. Humira: 5 people, 15.62%

Common side effects people have besides Lipase increased *:

  1. Pancreatitis (inflammation of pancreas): 21 people, 65.62%
  2. Drug Hypersensitivity: 18 people, 56.25%
  3. Nausea (feeling of having an urge to vomit): 6 people, 18.75%
  4. Abdominal Pain: 4 people, 12.50%
  5. Nausea And Vomiting: 4 people, 12.50%
  6. Thrombocytopenia (decrease of platelets in blood): 3 people, 9.38%
  7. Blood Amylase Increased: 3 people, 9.38%
  8. Fever: 3 people, 9.38%
  9. Fatigue (feeling of tiredness): 3 people, 9.38%
  10. Diarrhea: 2 people, 6.25%

Common conditions people have *:

  1. Pain: 2 people, 6.25%
  2. Psychotic Disorder: 1 person, 3.12%
  3. Proctitis Ulcerative (inflammation of the rectum and anus ulcerative): 1 person, 3.12%
  4. Indigestion: 1 person, 3.12%
  5. Gastroenteritis (inflammation of stomach and intestine): 1 person, 3.12%
  6. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Mesalamine and have Lipase increased?

Check whether Lipase increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Lipase increased and when was it recovered:

Expand to all the drugs that have ingredients of mesalamine:

Alternative drugs to, pros and cons of Mesalamine:

Common Mesalamine side effects:

Browse all side effects of Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Lipase increased treatments and more:

COVID vaccines that are related to Lipase increased:

Common drugs associated with Lipase increased:

All the drugs that are associated with Lipase increased:

Common conditions associated with Lipase increased:

All the conditions that are associated with Lipase increased:

How the study uses the data?

The study uses data from the FDA. It is based on mesalamine (the active ingredients of Mesalamine) and Mesalamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: